Intrahepatic chronic inflammation plays a central role in NASH and HCC, and the role of TNFα and IL-6, activating oncogenic STAT3 signaling, was demonstrated in dietary and genetic obesity-induced HCC development [129]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.